Dare Bioscience (DARE) Revenue (2014 - 2026)
Dare Bioscience's (DARE) quarterly Revenue came in at $1.0 million in Q4 2025, up 1708.36% YoY from $56607.8 in Q4 2024, and up 45155.35% on a QoQ basis from $2262.0 in Q3 2025.
Dare Bioscience (DARE) Revenue (2014 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 7 years of Revenue data on file, last reported at $1.0 million in Q4 2025.
- Quarterly Revenue rose 1708.36% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (up 10429.36% YoY) and the FY2025 annual result came in at $1.0 million, up 10429.36% from the prior year.
- Revenue climbed to $1.0 million in Q4 2025, from $2262.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $10.0 million in Q2 2022 to a low of -$63647.0 in Q4 2024.
- A 4-year average of $1.3 million and a median of $25427.0 in 2025 frame the typical range for Revenue.
- The widest YoY moves for Revenue: up 1708.36% in 2025, down 194.36% in 2025.
- Tracing DARE's Revenue over 4 years: stood at $10.0 million in 2022, then slumped by 81.92% to $1.8 million in 2023, then plunged by 103.52% to -$63647.0 in 2024, then surged by 1708.36% to $1.0 million in 2025.
- The last three Revenue figures came in at $1.0 million (Q4 2025), $2262.0 (Q3 2025), and -$21172.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Dare Bioscience | 11.91 Mn | -705,728.22 | -132,343.00 | 187,546.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 187,546.00 |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 2,262.00 |
| Jun 30, 2025 | -21,172.00 |
| Mar 31, 2025 | 25,427.00 |
| Dec 31, 2024 | -63,647.00 |
| Sep 30, 2024 | 41,691.00 |
| Jun 30, 2024 | 22,438.00 |
| Mar 31, 2024 | 9,302.00 |
| Dec 31, 2023 | 1.81 Mn |
| Sep 30, 2023 | 1.00 Mn |
| Jun 30, 2022 | 10.00 Mn |
| Jun 30, 2017 | 642,000.00 |
| Mar 31, 2017 | 1.19 Mn |
| Dec 31, 2016 | 766,000.00 |
| Jun 30, 2014 | 33,000.00 |
| Mar 31, 2014 | 47,000.00 |